Adenoviral delivery of TGFβ1 to the anterior chamber of the mouse eye produced the formation of distinct subcapsular cataracts, 4 days post injection, which exhibited features of ASC plaques described in humans and other rodent models, including an induction in αSMA expression and aberrant deposition of ECM. The gene discussed is TGFB1; the disease is cataract.